CH229084A - Verfahren zur Darstellung des Mono-phosphorsäureesters des 3,3'-Methylen-bis-4,4'-oxy-cumarins. - Google Patents
Verfahren zur Darstellung des Mono-phosphorsäureesters des 3,3'-Methylen-bis-4,4'-oxy-cumarins.Info
- Publication number
- CH229084A CH229084A CH229084DA CH229084A CH 229084 A CH229084 A CH 229084A CH 229084D A CH229084D A CH 229084DA CH 229084 A CH229084 A CH 229084A
- Authority
- CH
- Switzerland
- Prior art keywords
- sep
- bis
- oxy
- coumarin
- acid ester
- Prior art date
Links
- 239000002253 acid Substances 0.000 title claims description 7
- 238000000034 method Methods 0.000 title claims description 5
- 150000002148 esters Chemical class 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title claims description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 6
- 239000011230 binding agent Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 2
- 239000000155 melt Substances 0.000 claims description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 229960000956 coumarin Drugs 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000001671 coumarin Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 150000003014 phosphoric acid esters Chemical class 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- YLOVYOQKFPEOLM-UHFFFAOYSA-N phosphooxychloride Chemical compound ClOP(=O)=O YLOVYOQKFPEOLM-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
- C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH229084T | 1942-06-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH229084A true CH229084A (de) | 1943-09-30 |
Family
ID=4455907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH229084D CH229084A (de) | 1942-06-09 | 1942-06-09 | Verfahren zur Darstellung des Mono-phosphorsäureesters des 3,3'-Methylen-bis-4,4'-oxy-cumarins. |
Country Status (2)
| Country | Link |
|---|---|
| BE (1) | BE449545A (en, 2012) |
| CH (1) | CH229084A (en, 2012) |
-
0
- BE BE449545D patent/BE449545A/xx unknown
-
1942
- 1942-06-09 CH CH229084D patent/CH229084A/de unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE449545A (en, 2012) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH229084A (de) | Verfahren zur Darstellung des Mono-phosphorsäureesters des 3,3'-Methylen-bis-4,4'-oxy-cumarins. | |
| DE1617463A1 (de) | Verfahren zur Herstellung von injizierbaren kolloidalen Eisenzubereitungen | |
| DE921870C (de) | Verfahren zur Herstellung von 0, 0-Dimethyl-0-4-nitro-3-chlorphenyl-thiophosphat | |
| DE2107866C3 (de) | Thiamphenicolderivate, Verfahren zu deren Herstellung und anübakterielles Mittel | |
| DE613125C (de) | Verfahren zur Darstellung von wasserloeslichen Verbindungen der Oxydiphenylaether und deren Substitutionsprodukten | |
| DE2238260C3 (de) | Phosphorsäuremonoester von 5-(2-Dimethylaminoäthoxy)-carvacrol, Verfahren zu seiner Herstellung und diesen enthaltende Arzneimittel | |
| DE454701C (de) | Verfahren zur Darstellung von in der 3, 4-Stellung symmetrisch disubstituierten Derivaten des Arsenostibiobenzols | |
| AT151657B (de) | Verfahren zur Darstellung von Formaldehydnatriumsulfoxylaten von Arsenobenzolverbindungen. | |
| AT117475B (de) | Verfahren zur Darstellung von Substitutionsprodukten des ß-Jodpyridins. | |
| AT162289B (de) | Verfahren zur Herstellung von Estern des 1-Alkyl-4-oxypiperidins | |
| DE258297C (en, 2012) | ||
| DE270255C (en, 2012) | ||
| AT216004B (de) | Verfahren zur Herstellung des neuen N-(4-Sulfonamidophenyl)-butansultam | |
| DE1620675C (de) | S-Benzoyloxymethylthiamine und Verfahren zu deren Herstellung | |
| DE859790C (de) | Verfahren zur Erhoehung der Loeslichkeit von Sulfonamiden | |
| AT160493B (de) | Verfahren zur Herstellung radioaktiver Gewebe. | |
| DE1947256C3 (de) | Orotsäurederivate mit verbesserter Wasserlöslichkeit und Verfahren zu ihrer Herstellung | |
| AT157720B (de) | Verfahren zur Herstellung von Glucosiden. | |
| DE944953C (de) | Verfahren zur Herstellung eines aus dem Calciumsalz der Ca-AEthylen-diamintetraessigsaeure bestehenden Therapeutikums | |
| DE810027C (de) | Verfahren zur Herstellung eines neuartigen Abkoemmlings des ª‡-Phenylaethylalkohols | |
| DE567275C (de) | Verfahren zur Herstellung von loeslichen Arsen-Wismut-Verbindungen | |
| AT249031B (de) | Verfahren zur Herstellung von neuen Derivaten des Chloramphenicols | |
| AT263814B (de) | Verfahren zur Herstellung eines neuen Poly-γ-propylsulfosäureäthers des Inulins | |
| AT247519B (de) | Verfahren zur Herstellung neuer Additionsverbindungen von Antibiotika | |
| DE1006415B (de) | Verfahren zur Herstellung von p-Nitrobenzaldoxim |